- User Conference Previews eClinical Advancements
NEWTOWN, Pennsylvania,
March 4, 2015 /PRNewswire/
-- BioClinica®, Inc., a leading specialty clinical trials
services and technology provider, today announced that clinical
trial professionals representing 20 organizations and 10 countries
convened at its annual European User Conference in Barcelona, Spain to discuss the use of its
eClinical technologies to overcome clinical development challenges.
BioClinica's eClinical technologies include: the Microsoft
Office-Smart OnPoint CTMS; Express EDC; Trident IRT; predictive
clinical supply Optimizer; and Compass, the risk-based intelligent
monitoring solution.
Logo -
http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
Representatives from top pharma, medical device and biotech
companies as well as CROs led presentations and case studies
including Nestlé, ClinTec International, Isis Pharmaceuticals,
inVentiv Health, Biosense Webster, Janssen, Amarantus BioScience,
Cerbomed, and others. Martijn
Princen, BioClinica's Head of European eClinical Sales,
remarked, "The event gives us another window into the pressing
needs of our customers and helps our product development team
respond with fresh approaches. It is also an effective forum where
they can exchange valuable experiences and successes using
BioClinica products."
BioClinica Vice President of Product Development, Chip
deVillafranca, discussed recent strides made to keep customers'
clinical trials on the leading edge with enhancements including
integration, analytics, workflow, usability, mobility, and
self-service functionality. Product innovations were showcased in
hands-on demonstrations. The keynote, "Putting Risk-Based
Monitoring (RBM) into Practice," was delivered by Boehringer
Ingelheim's Global Project Team Leader for RBM implementation
Mireille Zerola, a member of the
TransCelerate Biopharma RBM work stream. She shared about her
company's journey in implementing its own RBM solution, serving as
an incubator of innovation for others.
Zerola later teamed with BioClinica's Vice President of Clinical
Innovation, Courtney McBean on an
interactive session about obstacles to RBM implementation. The two
RBM experts showed how Compass can ease the transition to
centralized and off-site monitoring taking a risk-based, quality
management approach. They will further explore this topic in an
upcoming live webinar to be hosted by BioClinica on March 5th, Overcoming Barriers to Risk
Based Monitoring.
Upcoming events featuring BioClinica's experts and eClinical
technologies include:
- Clinical Innovations Congress, London, United Kingdom, March 10-11
- Association for Clinical Data Management Annual Conference,
Brussels, Belgium, March 18
- BioClinica Global User Conference, Orlando Florida, USA, May
5-6
- Outsourcing in Clinical Trials Europe, Dusseldorf, Germany, May 19-20
About BioClinica, Inc.
BioClinica accelerates the development of new medical therapies
by delivering expertise and technologies that enhance clinical
research, worldwide. Our industry-leading medical imaging services,
cardiac safety, and enterprise eClinical platform bring a new level
of quality and efficiency to every phase of clinical development.
Our experience spans three decades and includes thousands of
studies in all therapeutic areas, from design and management,
through submission and post-approval. BioClinica serves more than
400 pharmaceutical, biotechnology, and device companies – including
all the top 20 - through a network of offices in the U.S.,
Europe, and Asia.